Publication | Open Access

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study

MedicineCns MetastasesPathologyDose-expansion StudyBronchial NeoplasmCancer TreatmentCancer GeneticsOncologyCell BiologyPhase 1Lung CancerMolecular Oncology